Posters Development of a scalable upstream platform process with 1E15 vgL bioreactor titer for AAV October 25, 2023
Posters Development of a robust potency assay the gateway to understanding thes tructure-function relationship in AAV gene therapy October 25, 2023
Journal Articles Goody Two Plasmides: An optimized transient transfection system for AAV production August 9, 2023
Journal Articles A novel dual-plasmid platform provides scalable transfection yielding improved productivity and packaging across multiple AAV serotypes and genomes May 30, 2023
Posters Gene EXPRESSion Platform: Enabling Early Potency Development and Stability Assessment May 30, 2023
Posters Optimizing Helper Plasmids by Removing Unnecessary “Junk” DNA Significantly Increases AAV Productivity May 30, 2023
White papers Achieving rAAV Bioreactor Titer of >1E15 vg/L With Novel Plasmid Transient Transfection Platform October 12, 2022
Posters Achieving AAV Vector Productivity >1E15vg/L and Scaling Suspension Transfection to 2,000L Through Upstream Process Optimization October 11, 2022
Posters Novel AAV Drug Product Formulation Achieving Long-Term Liquid State Stability (2-8°C) and High Titer Preparations (>E15vg/mL) October 11, 2022
Webinars Scaling Up an AAV Production Platform to Support Clinical and Commercial Needs: Challenges and Opportunities September 20, 2022
Podcasts The BioInsights Podcast: Achieving Better AAV Vector Productivity and Product Quality August 5, 2022
White papers Novel Dual-Plasmid Transfection System Improves Titer and Product Quality in AAV Manufacturing July 15, 2022
Posters A Novel Dual Plasmid Platform Provides a Scalable Transfection Process Yielding Improved Productivity and Packaging Compared to Triple and pDG Dual Plasmids May 16, 2022